Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-volume prostate biopsy core involvement is not associated with an increased risk of cancer recurrence following 5-fraction stereotactic body radiation therapy monotherapy.
Lischalk JW, Sanchez A, Santos VF, Mendez C, Akerman M, Carpenter T, Tam M, Byun D, Wise DR, Mahadevan A, Evans A, Huang W, Katz A, Lepor H, Haas JA. Lischalk JW, et al. Among authors: wise dr. Radiat Oncol. 2024 Mar 4;19(1):29. doi: 10.1186/s13014-023-02397-z. Radiat Oncol. 2024. PMID: 38439040 Free PMC article.
Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile.
Adorno Febles VR, Hao Y, Ahsan A, Wu J, Qian Y, Zhong H, Loeb S, Makarov DV, Lepor H, Wysock J, Taneja SS, Huang WC, Becker DJ, Balar AV, Melamed J, Deng FM, Ren Q, Kufe D, Wong KK, Adeegbe DO, Deng J, Wise DR. Adorno Febles VR, et al. Among authors: wise dr. Prostate. 2023 Jun;83(9):840-849. doi: 10.1002/pros.24524. Epub 2023 Mar 29. Prostate. 2023. PMID: 36988342
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.
Shore N, Nielsen SM, Esplin ED, Antonarakis ES, Barata PC, Beer TM, Beltran H, Bryce A, Cookson MS, Crawford ED, Dorff TB, George DJ, Heath EI, Helfand BT, Hussain M, Mckay RR, Morgans AK, Morris MJ, Paller CJ, Ross AE, Sartor O, Shen J, Sieber P, Smith MR, Wise DR, Armstrong AJ. Shore N, et al. Among authors: wise dr. JCO Oncol Pract. 2024 Dec 19:OP2400626. doi: 10.1200/OP-24-00626. Online ahead of print. JCO Oncol Pract. 2024. PMID: 39700441
Reply by Authors.
Shore N, Pieczonka C, Heron S, Gazi M, Cahn D, Belkoff LH, Berger A, Mazzarella B, Veys J, Idom C, Morris D, Jayram G, Engelman A, Dato P, Bevan-Thomas R, Wise DR, Hardwick MK, Rojahn S, Layman P, Heald B, Ellsworth RE, Hatchell KE, Nussbaum RL, Nielsen SM, Esplin ED. Shore N, et al. Among authors: wise dr. J Urol. 2024 Dec;212(6):842-843. doi: 10.1097/JU.0000000000004221. Epub 2024 Sep 3. J Urol. 2024. PMID: 39226588 No abstract available.
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer.
Shore N, Pieczonka C, Heron S, Gazi M, Cahn D, Belkoff LH, Berger A, Mazzarella B, Veys J, Idom C, Morris D, Jayram G, Engelman A, Dato P, Bevan-Thomas R, Wise DR, Hardwick MK, Rojahn S, Layman P, Heald B, Ellsworth RE, Hatchell KE, Nussbaum RL, Nielsen SM, Esplin ED. Shore N, et al. Among authors: wise dr. J Urol. 2024 Dec;212(6):832-843. doi: 10.1097/JU.0000000000004190. Epub 2024 Aug 9. J Urol. 2024. PMID: 39121056
TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.
Loeb S, Keith SW, Cheng HH, Leader AE, Gross L, Sanchez Nolasco T, Byrne N, Hartman R, Brown LH, Pieczonka CM, Gomella LG, Kelly WK, Lallas CD, Handley N, Mille PJ, Mark JR, Brown GA, Chopra S, McClellan A, Wise DR, Hollifield L, Giri VN. Loeb S, et al. Among authors: wise dr. JCO Precis Oncol. 2024 Mar;8:e2300552. doi: 10.1200/PO.23.00552. JCO Precis Oncol. 2024. PMID: 38452310 Free PMC article. Clinical Trial.
73 results